Skip to content

Clinical trials

Esophageal Neoplasms trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Country / region: Hong Kong Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20131
20171
20193
20202
20222
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting3
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Chinese University of Hong Kong2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Amgen1
Bayer1
Hoffmann-La Roche1
Merck Sharp & Dohme LLC1
Shanghai Chest Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms11
Esophageal Squamous Cell Carcinoma4
Carcinoma, Non-Small-Cell Lung2
Colorectal Neoplasms2
Neoplasms2
Squamous Cell Carcinoma of Head and Neck2
Stomach Neoplasms2
Adenocarcinoma, Clear Cell1
Anus Neoplasms1
Biliary Tract Neoplasms1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.